ABCELLERA BIOLOGICS INC's ticker is ABCL and the CUSIP is 00288U106. A total of 131 filers reported holding ABCELLERA BIOLOGICS INC in Q1 2022. The put-call ratio across all filers is 0.31 and the average weighting 1.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,251,927 | +297.7% | 272,158 | +458.5% | 0.03% | +287.5% |
| Q2 2023 | $314,783 | -68.2% | 48,728 | -50.2% | 0.01% | -71.4% |
| Q4 2022 | $991,139 | -46.5% | 97,842 | -43.7% | 0.03% | -66.3% |
| Q2 2022 | $1,852,000 | -17.7% | 173,864 | -24.7% | 0.08% | -21.7% |
| Q1 2022 | $2,251,000 | +175.5% | 230,872 | +304.3% | 0.11% | +112.0% |
| Q4 2021 | $817,000 | +234.8% | 57,107 | +414.4% | 0.05% | +138.1% |
| Q2 2021 | $244,000 | – | 11,102 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DCVC Bio GP, LLC | 29,411 | $313,000 | 100.00% |
| Founders Fund VII Management, LLC | 3,773,530 | $40,188,000 | 93.02% |
| Gruss & Co., LLC | 363,778 | $3,874,000 | 26.99% |
| Founders Fund Growth Management, LLC | 407,017 | $4,334,000 | 12.66% |
| GUARDIAN CAPITAL ADVISORS LP | 3,836,414 | $44,387,000 | 5.09% |
| HARVARD MANAGEMENT CO INC | 4,105,095 | $43,719,000 | 5.06% |
| Intellectus Partners, LLC | 1,089,755 | $11,606,000 | 3.99% |
| ArchPoint Investors | 630,326 | $6,713,000 | 2.66% |
| BRANDYWINE MANAGERS, LLC | 56,976 | $607,000 | 1.49% |
| Orbimed Advisors | 4,180,768 | $44,525,000 | 0.81% |